Physician

Rithwick Rajagopal, MD

According to 2025 Medicare claims, Rithwick Rajagopal, MD (NPI: 1679779912) practices ophthalmology in the St. Louis, MO-IL market, with the plurality of this provider's patient population coming from St. Louis, MO. This provider's primary affiliated billing organization is WASHINGTON UNIVERSITY (NPI: 1013957562; TIN: 430653611) and primary practice location at 63141-6809.

Rajagopal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 351 traditional Medicare patients, billed 3,926 HCPCS/CPT codes, and received $782,516 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 397 prescription claims across 93 beneficiaries totaling $14,555 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $427,303 to $782,516. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$432K$863K2015 Medicare payment: $427,303 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $560,580 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $577,397 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $576,271 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $476,901 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $425,269 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $587,194 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $670,384 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $863,233 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $782,516 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153562,615$427,303
20163913,004$560,580
20173703,085$577,397
20183682,916$576,271
20193562,563$476,901
20202902,175$425,269
20213162,425$587,194
20222922,486$670,384
20233593,784$863,233
20243513,926$782,516

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$7.3K$15K2015 Drug cost: $12,373 (USD; Tot_Drug_Cst)2016 Drug cost: $11,575 (USD; Tot_Drug_Cst)2017 Drug cost: $10,236 (USD; Tot_Drug_Cst)2018 Drug cost: $9,044 (USD; Tot_Drug_Cst)2019 Drug cost: $3,011 (USD; Tot_Drug_Cst)2020 Drug cost: $3,965 (USD; Tot_Drug_Cst)2021 Drug cost: $4,356 (USD; Tot_Drug_Cst)2022 Drug cost: $5,401 (USD; Tot_Drug_Cst)2023 Drug cost: $12,726 (USD; Tot_Drug_Cst)2024 Drug cost: $14,555 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201543123$12,373
201646154$11,575
201745155$10,236
201840131$9,044
201931102$3,011
202033104$3,965
202137113$4,356
202241140$5,401
202370313$12,726
202493397$14,555

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg93928$656
67028Injection of drug into eye104465$80
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more168238$62
92134Imaging of retina336871$28
92201Extended exam of the back part of the eye with retinal drawing111125$18

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1013,515$3,538
Ketorolac TromethamineKetorolac Tromethamine1113,598$1,650
Brimonidine TartrateBrimonidine Tartrate381,925$1,174
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat523,654$462
Dorzolamide HclDorzolamide Hcl191,256$438

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Rithwick Rajagopal, MD?

Tedicare shows public-source Medicare data for Rithwick Rajagopal, MD (NPI 1679779912), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rithwick Rajagopal, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rithwick Rajagopal, MD?

Rithwick Rajagopal, MD is linked to WASHINGTON UNIVERSITY (billing NPI 1013957562) in the available physician profile data.

Does Rithwick Rajagopal, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.